MGX Metagenomi Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 10, 2026
$1.02
· of 52w range
· above low
· to high
$1.0252w low
$3.9552w high
Market Cap (MRQ)
$39M
P/E
-0.4
EPS
$-2.36
Revenue
$25M
your badges
52W Range
$1–$4
Analyst Rating
BUY
Price Target
$7
P/E
-0.4
ROE
-49.6%
Net Profit Margin
-348.5%
Your badge strip is empty — pin a metric anywhere on this page.
MGX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.02
Market Cap (MRQ)
$39M
P/E
-0.4
EPS
$-2.36
Revenue
$25M
ROE
-49.6%
52W Range
$1–$4
MGX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$25M2023-12-31 → 2025-12-31
EPS$-2.362023-12-31 → 2025-12-31
Free Cash Flow$-89M2024-12-31 → 2025-12-31
Net margin-348.5%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MGX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.4 | · | · | · | |
| P/S | 1.5 | · | · | · | |
| P/B (MRQ) | 0.3 | · | 0.9 | Undervalued | |
| Price / FCF (TTM) | -0.4 | · | · | · | |
| Price / Cash Flow (TTM) | -0.5 | · | · | · | |
| Price / Tangible Book | 0.2 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MGX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -380.9% | · | -639.7% | Weak | |
| EBITDA Margin | -380.9% | · | -639.7% | Weak | |
| Pretax Margin | -348.8% | · | -558.8% | Weak | |
| Net Profit Margin | -348.5% | · | -564.6% | Weak | |
| ROA | -32.2% | · | -47.1% | Top tier | |
| ROE | -49.6% | · | -149.4% | Top tier | |
| ROIC | -60.5% | · | -159.9% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MGX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.5 | · | 2.6 | Strong liquidity | |
| Quick Ratio | 1.8 | · | 1.7 | Below avg |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | MGX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -51.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MGX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | Top tier | |
| Receivables Turnover | 32.3 | · | · | · | |
| Revenue / Employee | ≈$223.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-5.9%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 19, 2026 | $-0.73 | $-0.58 | -26.6% |
| March 31, 2026 | May 19, 2026 | $-0.61 | $-0.53 | -14.7% |
| Dec. 31, 2025 | $-0.60 | $-0.61 | 1.9% | |
| Sept. 30, 2025 | $-0.55 | $-0.59 | 6.7% | |
| June 30, 2025 | $-0.54 | $-0.63 | 13.9% | |
| March 31, 2025 | $-0.68 | $-0.58 | -16.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $52M | $45M | |
| R&D Expense | $94M | $109M | $94M | |
| SG&A Expense | $27M | $32M | $29M | |
| Operating Expenses | $121M | $141M | $123M | |
| Operating Income | $-96M | $-89M | $-78M | |
| Interest Income | $9M | $15M | $15M | |
| Other Non-op | $-91.0K | $-207.0K | $-74.0K | |
| Pretax Income | $-88M | $-84M | $-60M | |
| Income Tax | $-58.0K | $-6M | $8M | |
| Net Income | $-88M | $-78M | $-68M | |
| EPS (Basic) | $-2.36 | $-2.36 | $-20.05 | |
| EPS (Diluted) | $-2.36 | $-2.36 | $-20.05 | |
| Shares (Basic) | 37,251,050 | 33,027,889 | 3,404,585 | |
| Shares (Diluted) | 37,251,050 | 33,027,889 | 3,404,585 | |
| EBITDA | $-96M | $-89M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $42M | $27M | $141M | |
| Receivables | $305.0K | $1M | $2M | |
| Prepaid Expense | $4M | $8M | $5M | |
| Current Assets | $166M | $258M | $278M | |
| PP&E (Net) | $12M | $18M | $22M | |
| PP&E (Gross) | $28M | $29M | $28M | |
| Accum. Depreciation | $16M | $11M | $6M | |
| Other Non-current Assets | $836.0K | $287.0K | $5M | |
| Total Assets | $221M | $325M | $365M | |
| Accounts Payable | $1M | $533.0K | $2M | |
| Current Liabilities | $23M | $37M | $69M | |
| Capital Leases | $35M | $40M | $45M | |
| Other Non-current Liabilities | $2M | $2M | $5M | |
| Total Liabilities | $63M | $90M | $150M | |
| Common Stock | $4.0K | $4.0K | $0 | |
| Paid-in Capital | $469M | $457M | $9M | |
| Retained Earnings | $-311M | $-223M | $-145M | |
| AOCI | $260.0K | $709.0K | $-97.0K | |
| Stockholders' Equity | $159M | $235M | $-136M | |
| Liabilities + Equity | $221M | $325M | $365M | |
| Shares Outstanding | 37,620,668 | 37,418,470 | 3,404,585 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $12M | $16M | $7M | |
| Operating Cash Flow | $-89M | $-109M | $-91M | |
| CapEx | $574.0K | $3M | $10M | |
| Investing Cash Flow | $104M | $-88M | $46M | |
| Financing Cash Flow | $-356.0K | $84M | $1M | |
| Net Change in Cash | $14M | $-113M | $-45M | |
| Taxes Paid | $-2M | $4M | $2M | |
| Free Cash Flow | $-89M | $-112M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -380.9% | -170.0% | · | |
| Net Margin | -348.5% | -149.3% | · | |
| Pretax Margin | -348.8% | -159.8% | · | |
| EBITDA Margin | -380.9% | -170.0% | · | |
| ROA | -32.2% | -22.6% | · | |
| ROE | -49.6% | -31.8% | · | |
| ROIC | -60.5% | -35.4% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.2 | 6.9 | · | |
| Quick Ratio | 1.8 | 0.8 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | |
| Receivables Turnover | 32.3 | 28.2 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $4.22 | $6.28 | · | |
| Revenue / Share | $0.68 | $1.58 | · | |
| Cash Flow / Share | $-2.39 | $-3.30 | · | |
| Cash / Share | $1.11 | $0.73 | · | |
| EPS (TTM) | $-2.36 | $-2.36 | $-20.05 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -51.8% | 16.8% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $52M | $45M | |
| Net Income TTM | $-88M | $-78M | $-68M | |
| Market Cap | $61M | $135M | · | |
| P/E | -0.7 | -1.5 | · | |
| P/S | 2.4 | 2.6 | · | |
| P/B | 0.4 | 0.6 | · | |
| P / Tangible Book | 0.4 | 0.6 | · | |
| P / Cash Flow | -0.7 | -1.2 | · | |
| P / FCF | -0.7 | -1.2 | · | |
| Earnings Yield | -145.7% | -65.4% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $1M | $4M | $9M | $9M | $4M | $10M | $12M | $20M | $11M | $12M | $12M | $11M | $9M | |
| R&D Expense | $23M | $19M | $22M | $25M | $23M | $25M | $23M | $26M | $28M | $31M | $25M | $27M | $23M | $20M | |
| SG&A Expense | $6M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $9M | $9M | $8M | $8M | $7M | $6M | |
| Operating Expenses | $29M | $26M | $28M | $31M | $30M | $32M | $30M | $34M | $37M | $40M | $33M | $35M | $29M | $27M | |
| Operating Income | $-29M | $-25M | $-24M | $-23M | $-21M | $-28M | $-21M | $-22M | $-17M | $-29M | $-20M | $-22M | $-18M | $-18M | |
| Interest Income | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-op | $35.0K | $-1.0K | $-11.0K | $-2.0K | $-70.0K | $-8.0K | $-49.0K | $-57.0K | $-51.0K | $-50.0K | $-4.0K | $-85.0K | $16.0K | $-1.0K | |
| Pretax Income | $-27M | $-23M | $-22M | $-21M | $-20M | $-25M | $-25M | $-21M | $-13M | $-25M | $-17M | $-19M | $-11M | $-14M | |
| Income Tax | $0 | $10.0K | $34.0K | $-234.0K | $44.0K | $98.0K | $-1M | $-2M | $-2M | $0 | $7M | $1M | $2M | $-2M | |
| Net Income | $-27M | $-23M | $-23M | $-20M | $-20M | $-25M | $-23M | $-19M | $-11M | $-25M | $-19M | $-20M | $-13M | $-16M | |
| EPS (Basic) | $-0.73 | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| EPS (Diluted) | $-0.73 | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| Shares (Basic) | 37,658,250 | 37,581,094 | · | 37,349,449 | 37,156,979 | 37,019,027 | · | 36,766,309 | 36,625,291 | 21,137,868 | · | 3,404,585 | 3,404,585 | 3,404,585 | |
| Shares (Diluted) | 37,658,250 | 37,581,094 | · | 37,349,449 | 37,156,979 | 37,019,027 | · | 36,766,309 | 36,625,291 | 21,137,868 | · | 3,404,585 | 3,404,585 | 3,404,585 | |
| EBITDA | $-29M | $-25M | · | $-23M | $-21M | $-28M | · | $-22M | $-17M | $-29M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $25M | $42M | $33M | $27M | $29M | $27M | $25M | $61M | $103M | $141M | · | · | · | |
| Receivables | $0 | $0 | $305.0K | $960.0K | $900.0K | $900.0K | $1M | $589.0K | $2M | $2M | $2M | · | · | · | |
| Prepaid Expense | $4M | $4M | $4M | $5M | $6M | $6M | $8M | $7M | $6M | $6M | $5M | · | · | · | |
| Current Assets | $124M | $145M | $166M | $190M | $212M | $233M | $258M | $282M | $308M | $336M | $278M | · | · | · | |
| PP&E (Net) | $10M | $11M | $12M | $14M | $15M | $17M | $18M | $20M | $21M | $21M | $22M | · | · | · | |
| PP&E (Gross) | · | · | $28M | · | · | · | $29M | · | · | · | $28M | · | · | · | |
| Accum. Depreciation | · | · | $16M | · | · | · | $11M | · | · | · | $6M | · | · | · | |
| Other Non-current Assets | $1M | $927.0K | $836.0K | $809.0K | $805.0K | $781.0K | $287.0K | $320.0K | $332.0K | $379.0K | $5M | · | · | · | |
| Total Assets | $174M | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Accounts Payable | $3M | $2M | $1M | $1M | $3M | $3M | $533.0K | $3M | $3M | $7M | $2M | · | · | · | |
| Current Liabilities | $28M | $22M | $23M | $30M | $33M | $40M | $37M | $46M | $53M | $71M | $69M | · | · | · | |
| Capital Leases | $31M | $33M | $35M | $36M | $37M | $39M | $40M | $41M | $43M | $44M | $45M | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | · | · | · | |
| Total Liabilities | $61M | $59M | $63M | $69M | $76M | $85M | $90M | $103M | $116M | $140M | $150M | · | · | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $0 | · | · | · | |
| Paid-in Capital | $474M | $472M | $469M | $466M | $463M | $460M | $457M | $454M | $451M | $446M | $9M | · | · | · | |
| Retained Earnings | $-361M | $-334M | $-311M | $-288M | $-268M | $-248M | $-223M | $-200M | $-181M | $-170M | $-145M | · | · | · | |
| AOCI | $-122.0K | $-44.0K | $260.0K | $371.0K | $372.0K | $621.0K | $709.0K | $2M | $-265.0K | $-278.0K | $-97.0K | · | · | · | |
| Stockholders' Equity | $113M | $138M | $159M | $178M | $196M | $213M | $235M | $256M | $269M | $276M | $-136M | · | · | · | |
| Liabilities + Equity | $174M | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Shares Outstanding | 37,777,105 | 37,647,057 | 37,620,668 | 37,546,751 | 37,533,136 | 37,382,478 | 37,418,470 | 37,432,832 | 37,459,853 | 37,468,078 | 3,404,585 | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $2M | $3M | $656.0K | $529.0K | |
| Operating Cash Flow | $-20M | $-21M | $-24M | $-21M | $-21M | $-23M | $-26M | $-27M | $-26M | $-30M | $-21M | $-24M | $-26M | $-21M | |
| CapEx | $125.0K | $25.0K | $85.0K | $74.0K | $127.0K | $288.0K | $334.0K | $1M | $665.0K | $915.0K | $2M | $2M | $3M | $3M | |
| Investing Cash Flow | $33M | $4M | $32M | $27M | $19M | $25M | $29M | $-9M | $-13M | $-95M | $61M | $76M | $-19M | $-72M | |
| Financing Cash Flow | $67.0K | $-27.0K | $74.0K | $-187.0K | $-166.0K | $-77.0K | $0 | $-492.0K | $-2M | $87M | $-1M | $-2M | $-39.0K | $4M | |
| Net Change in Cash | $14M | $-17M | $9M | $6M | $-2M | $2M | $2M | $-36M | $-41M | $-38M | $39M | $50M | $-45M | $-89M | |
| Free Cash Flow | · | $-21M | · | · | · | $-23M | · | · | · | $-31M | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| Net Margin | · | -1847.7% | · | -235.5% | -233.8% | -606.7% | · | -163.0% | -53.7% | -225.4% | · | · | · | · | |
| Pretax Margin | · | -1846.9% | · | -238.2% | -233.3% | -604.3% | · | -181.3% | -64.7% | -225.4% | · | · | · | · | |
| EBITDA Margin | · | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| ROA | -12.3% | -9.3% | · | -6.7% | -6.0% | -7.0% | · | -10.5% | -5.6% | -12.1% | · | · | · | · | |
| ROE | -17.8% | -13.2% | · | -9.4% | -8.6% | -10.3% | · | -14.7% | -8.0% | -18.2% | · | · | · | · | |
| ROIC | -25.6% | -17.8% | · | -12.7% | -10.7% | -13.1% | · | -7.9% | -5.2% | -10.5% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.4 | · | 6.4 | 6.4 | 5.8 | · | 6.2 | 5.8 | 4.7 | · | · | · | · | |
| Quick Ratio | 1.4 | 1.1 | · | 1.1 | 0.8 | 0.8 | · | 0.6 | 1.2 | 1.5 | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Receivables Turnover | · | 2.8 | · | 11.2 | 6.7 | 2.8 | · | 39.1 | 24.3 | 10.7 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.98 | $3.66 | · | $4.75 | $5.22 | $5.69 | · | $6.83 | $7.19 | $7.36 | · | · | · | · | |
| Revenue / Share | · | $0.03 | · | $0.23 | $0.23 | $0.11 | · | $0.31 | $0.55 | $0.53 | · | · | · | · | |
| Cash Flow / Share | · | $-0.56 | · | · | · | $-0.62 | · | · | · | $-1.41 | · | · | · | · | |
| Cash / Share | $1.03 | $0.67 | · | $0.87 | $0.72 | $0.78 | · | $0.67 | $1.63 | $2.74 | · | · | · | · | |
| EPS (TTM) | $-2.48 | $-2.29 | · | $-2.14 | $-2.10 | $-1.85 | · | $-7.66 | $-12.97 | $-16.50 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $22M | · | $31M | $34M | $45M | · | $55M | $56M | $47M | · | · | · | · | |
| Net Income TTM | $-93M | $-86M | · | $-89M | $-87M | $-78M | · | $-74M | $-75M | $-77M | · | · | · | · | |
| Market Cap | $45M | $50M | · | $89M | $56M | $51M | · | $81M | $153M | $395M | · | · | · | · | |
| P/E | -0.5 | -0.6 | · | -1.1 | -0.7 | -0.7 | · | -0.3 | -0.3 | -0.6 | · | · | · | · | |
| P/S | 2.0 | 2.3 | · | 2.9 | 1.6 | 1.1 | · | 1.5 | 2.7 | 8.4 | · | · | · | · | |
| P/B | 0.4 | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Tangible Book | 0.4 | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Cash Flow | · | -2.4 | · | · | · | -2.2 | · | · | · | -13.2 | · | · | · | · | |
| Earnings Yield | -208.4% | -170.9% | · | -90.3% | -141.9% | -136.0% | · | -353.0% | -317.9% | -156.4% | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $25M | $52M | $45M |
| Operating Margin % | -380.9% | -170.0% | · |
| Net Income | $-88M | $-78M | $-68M |
| Diluted EPS | $-2.36 | $-2.36 | $-20.05 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Current Ratio | 7.2 | 6.9 | · |
| Quick Ratio | 1.8 | 0.8 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | $-89M | $-112M | · |
Institutional owners (13F) 51 filers · $11.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
51
Value held
$11.5M
New positions
4
Exited positions
8
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (-1 vs prior Q) | 8 (-3 vs prior Q) | 12 (+2 vs prior Q) | 13 (-2 vs prior Q) | -201K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2,057,799 | 1,270,246 | 17.90% | Shares |
| Sozo Ventures GP II, L.P. | $1,331,404 | 581,577 | 11.58% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,282,463 | 1,077,700 | 11.16% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $883,456 | 742,400 | 7.69% | Shares |
| Catalio Capital Management, LP | $629,502 | 528,993 | 5.48% | Shares |
| Peapod Lane Capital LLC | $624,779 | 525,024 | 5.44% | Shares |
| TWO SIGMA INVESTMENTS, LP | $611,304 | 513,701 | 5.32% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $476,357 | 400,300 | 4.14% | Shares |
| WELLS FARGO & COMPANY/MN | $451,614 | 379,508 | 3.93% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $343,672 | 288,665 | 2.99% | Shares |
| TWO SIGMA ADVISERS, LP | $326,106 | 201,300 | 2.84% | Shares |
| PURA VIDA INVESTMENTS, LLC | $314,625 | 264,391 | 2.74% | Shares |
| BlackRock, Inc. | $306,581 | 257,631 | 2.67% | Shares |
| Good Life Advisors, LLC | $296,000 | 200,000 | 2.58% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $203,789 | 171,251 | 1.77% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $190,400 | 160,000 | 1.66% | Shares |
| STATE STREET CORP | $142,622 | 119,850 | 1.24% | Shares |
| MILLENNIUM MANAGEMENT LLC | $135,690 | 114,025 | 1.18% | Shares |
| Man Group plc | $129,865 | 109,130 | 1.13% | Shares |
| Resolute Advisors LLC | $107,033 | 89,944 | 0.93% | Shares |
| Marquette Asset Management, LLC | $85,824 | 72,121 | 0.75% | Shares |
| NORTHERN TRUST CORP | $82,036 | 68,938 | 0.71% | Shares |
| RBF Capital, LLC | $76,185 | 64,021 | 0.66% | Shares |
| XTX Topco Ltd | $66,291 | 55,707 | 0.58% | Shares |
| BBR PARTNERS, LLC | $63,550 | 53,403 | 0.55% | Shares |
| JANE STREET GROUP, LLC | $45,691 | 38,396 | 0.40% | Shares |
| Fortitude Advisory Group L.L.C. | $44,256 | 37,190 | 0.39% | Shares |
| CITADEL ADVISORS LLC | $21,243 | 17,851 | 0.18% | Shares |
| Qube Research & Technologies Ltd | $20,052 | 16,850 | 0.17% | Shares |
| UBS Group AG | $18,794 | 15,793 | 0.16% | Shares |
| TWO SIGMA SECURITIES, LLC | $18,056 | 15,173 | 0.16% | Shares |
| Cubist Systematic Strategies, LLC | $17,682 | 7,461 | 0.15% | Shares |
| Vanguard Global Advisers, LLC | $15,936 | 13,392 | 0.14% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $15,228 | 12,797 | 0.13% | Shares |
| Peak Planning Group, LLC | $14,875 | 12,500 | 0.13% | Shares |
| Point72 Asia (Singapore) Pte. Ltd. | $11,665 | 4,922 | 0.10% | Shares |
| MEEDER ASSET MANAGEMENT INC | $6,540 | 5,496 | 0.06% | Shares |
| MORGAN STANLEY | $6,309 | 5,302 | 0.05% | Shares |
| Tower Research Capital LLC (TRC) | $6,307 | 5,300 | 0.05% | Shares |
| US BANCORP \DE\ | $5,355 | 4,500 | 0.05% | Shares |
| OSAIC HOLDINGS, INC. | $2,250 | 1,891 | 0.02% | Shares |
| JPMORGAN CHASE & CO | $1,915 | 1,596 | 0.02% | Shares |
| FMR LLC | $700 | 588 | 0.01% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $625 | 500 | 0.01% | Shares |
| Allworth Financial LP | $595 | 500 | 0.01% | Shares |
| Point72 (DIFC) Ltd | $318 | 134 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $246 | 207 | 0.00% | Shares |
| BARCLAYS PLC | $199 | 167 | 0.00% | Shares |
| CWM, LLC | $34 | 25 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $10 | 8 | 0.00% | Shares |
Company insiders 14 insiders · 7 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jian Irish | President and Chief Executive Officer | Sept. 8, 2026 S | 375,393 | 0 | 5 | $-15,647 |
| Pamela Wapnick | Chief Financial Officer | Sept. 8, 2026 S | 206,580 | 0 | 5 | $-14,139 |
| Matthew Wein | Title: General Counsel, Compliance Officer and Corporate Secretary | Sept. 8, 2026 S | 126,133 | 0 | 5 | $-2,623 |
| Sarah B. Noonberg | Chief Medical Officer | June 6, 2025 S | 109,135 | 0 | 0 | $0 |
| Simren Delaney | Title: Vice President of Intellectual Property and Legal Operations | April 1, 2024 A | 93,892 | 0 | 0 | $0 |
| Simon Harnest | Title: Chief Investment Officer and Senior Vice President of Strategy | April 1, 2024 A | 122,664 | 0 | 0 | $0 |
| Luis Borges | Chief Scientific Officer | April 1, 2024 A | 69,316 | 0 | 0 | $0 |
| Laurence Reid | Director | Sept. 9, 2026 P | 20,000 | 2 | 0 | $23,401 |
| Juergen Eckhardt | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Willard H Dere | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Eric Bjerkholt | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Brian C. Thomas | Director | Dec. 5, 2025 S | 2,510,960 | 0 | 2 | $-11,668 |
| Sebastian Bernales | Director | April 1, 2024 A | 1,896,445 | 0 | 0 | $0 |
| Novo Holdings A/S | 10% owner | Feb. 13, 2024 C | 1,739,175 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
MGX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$7.00
+586.3%
2 22.2%
Strong Buy
5 55.6%
Buy
2 22.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-03Mean target $7.00 +586.3%
← Below all targets
Current price $1.02
Low$5.00
Mean$7.00
High$9.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 10, 2026